BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 26796281)

  • 1. Epidermal growth factor-like domain 7 promotes cell invasion and angiogenesis in pancreatic carcinoma.
    Shen X; Han Y; Xue X; Li W; Guo X; Li P; Wang Y; Li D; Zhou J; Zhi Q
    Biomed Pharmacother; 2016 Feb; 77():167-75. PubMed ID: 26796281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting EGFL7 expression through RNA interference suppresses renal cell carcinoma growth by inhibiting angiogenesis.
    Xu HF; Chen L; Liu XD; Zhan YH; Zhang HH; Li Q; Wu B
    Asian Pac J Cancer Prev; 2014; 15(7):3045-50. PubMed ID: 24815445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of the Epidermal Growth Factor-like Domain 7 and Inhibition of Migration and Epithelial-Mesenchymal Transition in Human Pancreatic Cancer PANC-1 Cells.
    Wang YL; Dong FL; Yang J; Li Z; Zhi QM; Zhao X; Yang Y; Li DC; Shen XC; Zhou J
    Asian Pac J Cancer Prev; 2015; 16(9):4065-9. PubMed ID: 25987088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lentivirus-mediated shRNA interference targeting vascular endothelial growth factor inhibits angiogenesis and progression of human pancreatic carcinoma.
    Zhao X; Zhu DM; Gan WJ; Li Z; Zhang JL; Zhao H; Zhou J; Li DC
    Oncol Rep; 2013 Mar; 29(3):1019-26. PubMed ID: 23254994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpressed MALAT1 promotes invasion and metastasis of gastric cancer cells via increasing EGFL7 expression.
    Deng QJ; Xie LQ; Li H
    Life Sci; 2016 Jul; 157():38-44. PubMed ID: 27259812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The study on clinical significance of the expression of EGFL7 in laryngeal squamous cell carcinoma].
    Gao S; Yang X; Li S; Tang Q
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Feb; 27(3):147-50. PubMed ID: 23700810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High calpain-1 expression predicts a poor clinical outcome and contributes to tumor progression in pancreatic cancer patients.
    Yu LM; Zhu YS; Xu CZ; Zhou LL; Xue ZX; Cai ZZ
    Clin Transl Oncol; 2019 Jul; 21(7):924-932. PubMed ID: 30565085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased expression of the endothelial cell-derived factor EGFL7 in systemic sclerosis: potential contribution to impaired angiogenesis and vasculogenesis.
    Manetti M; Guiducci S; Romano E; Avouac J; Rosa I; Ruiz B; Lepri G; Bellando-Randone S; Ibba-Manneschi L; Allanore Y; Matucci-Cerinic M
    Arthritis Res Ther; 2013 Oct; 15(5):R165. PubMed ID: 24286167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-vitro inhibitory effect of EGFL7-RNAi on endothelial angiogenesis in glioma.
    Li Q; Wang AY; Xu QG; Liu DY; Xu PX; Yu D
    Int J Clin Exp Pathol; 2015; 8(10):12234-42. PubMed ID: 26722408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. S100A4 silencing suppresses proliferation, angiogenesis and invasion of thyroid cancer cells through downregulation of MMP-9 and VEGF.
    Jia W; Gao XJ; Zhang ZD; Yang ZX; Zhang G
    Eur Rev Med Pharmacol Sci; 2013 Jun; 17(11):1495-508. PubMed ID: 23771538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expression and clinical significance of pSTAT3, VEGF and VEGF-C in pancreatic adenocarcinoma.
    Huang C; Huang R; Chang W; Jiang T; Huang K; Cao J; Sun X; Qiu Z
    Neoplasma; 2012; 59(1):52-61. PubMed ID: 22082308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidermal growth factor-like domain 7 promotes migration and invasion of human trophoblast cells through activation of MAPK, PI3K and NOTCH signaling pathways.
    Massimiani M; Vecchione L; Piccirilli D; Spitalieri P; Amati F; Salvi S; Ferrazzani S; Stuhlmann H; Campagnolo L
    Mol Hum Reprod; 2015 May; 21(5):435-51. PubMed ID: 25667199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EGFL7: Master regulator of cancer pathogenesis, angiogenesis and an emerging mediator of bone homeostasis.
    Hong G; Kuek V; Shi J; Zhou L; Han X; He W; Tickner J; Qiu H; Wei Q; Xu J
    J Cell Physiol; 2018 Nov; 233(11):8526-8537. PubMed ID: 29923200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of epidermal growth factor-like domain-containing protein 7 is predictive of poor prognosis in patients with hepatocellular carcinoma.
    Yang C; Wang YL; Sun D; Zhu XL; Li Z; Ni CF
    J Cancer Res Ther; 2018; 14(4):867-872. PubMed ID: 29970668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different expression of VEGF and EGFL7 in human hepatocellular carcinoma.
    Campagnolo L; Telesca C; Massimiani M; Stuhlmann H; Angelico M; Lenci I; Manzia TM; Tariciotti L; Lehmann G; Baiocchi L
    Dig Liver Dis; 2016 Jan; 48(1):76-80. PubMed ID: 26542361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
    Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
    Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel role for epidermal growth factor-like domain 7 in metastasis of human hepatocellular carcinoma.
    Wu F; Yang LY; Li YF; Ou DP; Chen DP; Fan C
    Hepatology; 2009 Dec; 50(6):1839-50. PubMed ID: 19824075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of epidermal growth factor-like domain 7 in pancreatic cancer.
    Zhou L; Li J; Zhao YP; Guo JC; Cui QC; Zhou WX; Zhang TP; Wu WM; You L; Shu H
    Hepatobiliary Pancreat Dis Int; 2014 Oct; 13(5):523-8. PubMed ID: 25308363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of EGFL7/EGFR-signaling pathway in migration and invasion of growth hormone-producing pituitary adenomas.
    Liu Q; Zhang J; Gao H; Yuan T; Kang J; Jin L; Gui S; Zhang Y
    Sci China Life Sci; 2018 Aug; 61(8):893-901. PubMed ID: 29951953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. STAT3-targeting RNA interference inhibits pancreatic cancer angiogenesis in vitro and in vivo.
    Huang C; Jiang T; Zhu L; Liu J; Cao J; Huang KJ; Qiu ZJ
    Int J Oncol; 2011 Jun; 38(6):1637-44. PubMed ID: 21479358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.